On the heels of receiving a Lloyd J. Old Star Program Grant for the study of the role of fungi in cancer development and immunotherapy, Dr. Iliyan Iliev has published a paper in Cell (September 29) that has revealed that the presence of some fungal species in tumors predicts—and may even help drive—worse cancer outcomes. This key breakthrough holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.
Dr. Iliev, Associate Professor of Immunology in Medicine, Division of Gastroenterology and Hepatology, WDOM, is senior author on the paper, and Dr. Steven Lipkin, the Gladys and Roland Harriman Professor of Medicine and WDOM’s Vice Chair for Research, is co-author.
Dr. Iliev is a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine.
This study was a collaborative effort including Weill Cornell Medicine and Duke University researchers.